Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-κb in prostatic carcinoma cell lines

Molecular Cancer Research

Volumn 2, Issue 10, 2004, Pages 574-584

  Guseva, Natalya V ^a   Taghiyev, Agshin F ^a   Sturm, Mary T ^a   Rokhlin, Oskar W ^a   Cohen, Michael B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOCHONDRIAL DNA; PROTEIN BCL 2; PROTEIN P50; PROTEIN SUBUNIT; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENOME; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

MAMMALIA;

EID: 6344235255     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cammarota M, Paratcha G, Bevilaqua LR, et al. Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem 1999;72:2272-7.
2. Foo SY, Nolan GP. NF-κB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 1999;15:229-35.
3. Zandi E, Karin M. Bridging the gap: composition, regulation, and physiological function of the IκB kinase complex. Mol Cell Biol 1999;19: 4547-51.
4. Carlotti F, Dower SK, Qwarnstrom EE. Dynamic shuttling of nuclear factor κB between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J Biol Chem 2000;275:41028-34.
5. Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR. Tumor necrosis factor-α-inducible IκBα proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-κB activation. J Biol Chem 1999;274:787-94.
6. Viatour P, Legrand-Poels S, van Lint C, et al. Cytoplasmic IκBα increases NF-κB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J Biol Chem 2003;278:46541-8.
7. Bottero V, Rossi F, Samson M, Mari M, Hofman P, Peyron JF. IκB-α, the NF-κB inhibitory subunit, interacts with ANT, the mitochondrial ATP/ADP translocator. J Biol Chem 2001;276:21317-24.
8. Cogswell PC, Kashatus DF, Keifer JA, et al. NF-κB and IκBα are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-κB. J Biol Chem 2003;278:2963-8.
9. Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 1998;8:1141-50.
10. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-68.
11. Young MR, Yang HS, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4. Trends Mol Med 2003;9:36-41.
12. Ogita K, Okuda H, Kitano M, Fujinami Y, Ozaki K, Yoneda Y. Localization of activator protein-1 complex with DNA binding activity in mitochondria of routine brain after in vivo treatment with kainate. J Neurosci 2002;22:2561-70.
13. Ogita K, Fujinami Y, Kitano M, Yoneda Y. Transcription factor activator protein-1 expressed by kainate treatment can bind to the non-coding region of mitochondrial genome in murine hippocampus. J Neurosci Res 2003;73:794-802.
14. Bossy-Wetzel E, Green DR. Apoptosis: checkpoint at the mitochondrial frontier. Mutat Res 1999;434:243-51.
15. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
16. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 2002;9:1031-42.
17. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
18. Strachan T, Read AP. The mitochondrial genome consists of small circular DNA duplex which is densely packed with genetic information. Chapter 7.1.1. In: Strachan T, Read AP, editors. Human molecular genetics (2/e). Oxford: BIOS Scientific Publishers Ltd.; 1999.
19. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 1997;7:821-30.
20. Jeremias I, Debatin KM. TRAIL induces apoptosis and activation of NFκB. Eur Cytokine Netw 1998;9:687-8.
21. Wallach D, Arumugam TU, Boldin MP, et al. How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family. Arthritis Res 2002;4 Suppl 3:S189-96.
22. Rokhlin OW, Guseva N, Tagiyev A, Knudson CM, Cohen MB. Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis. Oncogene 2001;20:2836-43.
23. Gasparian AV, Yao YJ, Kowalczyk D, et al. The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells. J Cell Sci 2002;115:141-51.
24. Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate 2002;52:1-11.
25. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996;274:784-7.
26. Chomyn A, Mariottini P, Cleeter MW, et al. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 1985;314:592-7.
27. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 1999;264:687-701.
28. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999;189:381-94.
29. Yoshida Y, Izumi H, Torigoe T, et al. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 2003;63:3729-34.
30. Scheller K, Seibel P, Sekeris CE. Glucocorticoid and thyroid hormone receptors in mitochondria of animal cells. Int Rev Cytol 2003;222:1-61.
31. Hsing Y, Bishop GA. Requirement for nuclear factor-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol 1999;162:2804-11.
32. Storrie B, Madden E. Isolation of subcellular organelles. Methods Enzymol 1990;182:203-25.
33. Rokhlin OW, Bishop GA, Hostager BS, et al. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997;57:1758-68.